CRM Devices Market Size Worth $32.4 Billion By 2025 | CAGR: 7.8%: Grand View Research, Inc.
SAN FRANCISCO, February 19, 2018 /PRNewswire/ --
The global cardiac rhythm management (CRM) devices market size is anticipated to reach USD 32.4 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.8% CAGR during the forecast period. Increase in demand for CRM devices can be attributed to supportive legislative policies by governments in developed and developing countries. Rising incidence of cardiovascular diseases (CVDs), supportive reimbursement scenario, and major advancements in technology are also anticipated to be key factors governing market growth.
CRM devices serve as a permanent treatment option for patients suffering from arrhythmias. Innovation in Cardiac Resynchronization Therapy (CRT) devices is expected to drive this market. Additionally, there is an increase in the application of implantable cardioverter-defibrillators (ICDs) as they are now integrated with pacemakers, thus increasing the product's life. Increase in demand for external defibrillators with growing in awareness and rising disease burden of sudden cardiac arrest (SCA) has also been observed. There is an expansion in the market for external defibrillators as governments in developed economies have been working on making countries more cardio-friendly.
According to statistics published by the Sudden Cardiac Arrest Foundation, about 6.0 million people within the U.S. region suffer from cardiac disorders, of which 0.8 million are affected by atrioventricular blockage, leading to cardiac failure. Such an alarming number leads to an increased cost of about USD 20-56 billion annually. CRM devices are being predominantly used to prevent surgical costs and readmission rates in hospitals, thereby propelling market growth.
Defibrillators held a lucrative share in 2016 and are also likely to grow at a profitable rate over the forecast period due to increase in prevalence of CVDs. These devices are normally used as continuous monitoring devices for arrhythmias
North America accounted for more than 35.0% of the overall market in 2016. This can be attributed to increasing incidence of cardiovascular diseases, supportive government policies, favorable reimbursement schemes available to patients, growing awareness, and rise in training programs
Asia Pacific was observed to be the fastest growing market for CRM devices with a CAGR nearly 9.0%. This is owing to increasing awareness and accessibility of CRM devices
Some of the key players operating in this space are St. Jude Medical; BIOTRONIK, Inc.; Medtronic; Boston Scientific Corporation; and ZOLL Medical Corporation.
Dental Equipment Market- The Global dental equipment market size was estimated at USD 6,081.4 million in 2013. Rising geriatric population has led to the high prevalence of age-related dental disorders, hence propelling the growth of this industry.
Enteral Feeding Devices Market - The global enteral feeding devices market was valued at USD 1,813.7 million in 2013 and is expected to grow at a CAGR of 6.0% during the forecast period to reach USD 2,720.8 million by 2020.
Burn Care Market - The global burn care market size was estimated at USD 1.66 billion in 2016. Increasing incidence of burn-related injuries is the major factor driving the market growth over the forecast period.
Grand View Research has segmented the global CRM devices market on the basis of product and region:
CRM Devices Product Outlook (Revenue, USD Million, 2014 - 2025)
Pacemakers
Implantable Pacemakers
External Pacemakers
Defibrillators
Implantable Cardioverter Defibrillators (ICDs)
Subcutaneous ICD (S-ICD)
Transvenous ICD (T-ICD)
External Defibrillator (ED)
Manual ED
Automated ED (AED)
Wearable Cardioverter Defibrillator
Cardiac Resynchronization Therapy (CRT)
CRT-Defibrillators (CRT-D)
CRT-Pacemakers (CRT-P)
CRM Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...
Denver nonprofit Justice Necessary unveils data from its latest study on teen period poverty in Colorado, shedding light on a deeply concerning issue. The findings of this study underscore the urgent need for action to address the need for teens to...
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...